Business Context and Reporting Period
Company: Concentra Group Holdings Parent, Inc. (NYSE: CON)
Filing Type: Form 8-K (Current Report)
Date of Report: January 12, 2026
Reporting Period: Preliminary, unaudited operational metrics for the quarter ended December 31, 2025.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. The report serves as a notification that preliminary operational metrics for the quarter ended December 31, 2025, are contained in an attached presentation (Exhibit 99.1) rather than within the body of the 8-K itself.
Material Changes
No material changes or comparative financial data are disclosed in the text of this filing. The document references a presentation to be delivered at the J.P. Morgan Healthcare Conference on January 14, 2026, which will detail the operational results.
Guidance, Outlook, and Risks
- Forward-Looking Statements: The filing includes standard disclaimers regarding forward-looking statements (e.g., expectations, plans, prospects). Actual results may differ materially due to various factors.
- Risk Factors: Investors are directed to the "Risk Factors" and "Forward-Looking Statements" sections of the Company's Annual Report on Form 10-K for the year ended December 31, 2024, filed on March 3, 2025.
- Legal Status: The information furnished is not deemed "filed" under Section 18 of the Exchange Act and is not incorporated by reference into other filings.
Investor Verification Checklist
- Review Exhibit 99.1 (Concentra Group Holdings Parent Inc. Presentation) for the actual preliminary operational metrics for Q4 2025.
- Access the recording of the J.P. Morgan Healthcare Conference presentation on the Company's investor relations website (https://ir.concentra.com/) following January 14, 2026.
- Consult the Form 10-K filed on March 3, 2025, for detailed risk factors and historical financial context.